Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia

Summary

This is a Phase 4, randomized, double-blind, placebo-controlled study to evaluate the persistence of effect of valbenazine 40 mg and 80 mg.

Timeline

Start

2019-03-18

Primary completion

2019-12-23

Completion

2020-01-30

Drugs

Indications